- Home
- CCCC vs AFCG Comparison
CCCC vs AFCG Comparison
Compare CCCC & AFCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- AFCG
- Stock Information
- Founded
- CCCC 2015
- AFCG 2020
- Country
- CCCC United States
- AFCG United States
- Employees
- CCCC N/A
- AFCG N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- AFCG Real Estate Investment Trusts
- Sector
- CCCC Health Care
- AFCG Real Estate
- Exchange
- CCCC Nasdaq
- AFCG Nasdaq
- Market Cap
- CCCC 115.0M
- AFCG 113.0M
- IPO Year
- CCCC 2020
- AFCG 2021
- Fundamental
- Price
- CCCC $1.50
- AFCG $5.77
- Analyst Decision
- CCCC Buy
- AFCG Buy
- Analyst Count
- CCCC 4
- AFCG 7
- Target Price
- CCCC $12.50
- AFCG $11.00
- AVG Volume (30 Days)
- CCCC 1.3M
- AFCG 116.7K
- Earning Date
- CCCC 05-07-2025
- AFCG 05-14-2025
- Dividend Yield
- CCCC N/A
- AFCG 22.90%
- EPS Growth
- CCCC N/A
- AFCG N/A
- EPS
- CCCC N/A
- AFCG 0.78
- Revenue
- CCCC $39,783,000.00
- AFCG $41,494,025.00
- Revenue This Year
- CCCC N/A
- AFCG N/A
- Revenue Next Year
- CCCC $36.31
- AFCG $23.25
- P/E Ratio
- CCCC N/A
- AFCG $7.40
- Revenue Growth
- CCCC 98.56
- AFCG N/A
- 52 Week Low
- CCCC $1.09
- AFCG $4.34
- 52 Week High
- CCCC $7.66
- AFCG $10.88
- Technical
- Relative Strength Index (RSI)
- CCCC 46.32
- AFCG 54.46
- Support Level
- CCCC $1.42
- AFCG $5.27
- Resistance Level
- CCCC $1.64
- AFCG $5.79
- Average True Range (ATR)
- CCCC 0.15
- AFCG 0.22
- MACD
- CCCC 0.02
- AFCG 0.10
- Stochastic Oscillator
- CCCC 25.64
- AFCG 86.21
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is a commercial mortgage REIT that provides institutional loans to cannabis operators in the U.S. Through the management team's deep network and related credit and cannabis expertise. The company originates, structures, and underwrites loans secured by quality real estate assets, license value, and cash flows.